# Medpace Holdings, Inc. (MEDP) FY2026 Q2 P&L / Income Statement

- Company: Medpace Holdings, Inc. (MEDP)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0001668397-26-000025
- Page: https://plicit.ai/financials/medp/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/medp-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue, net (includes $4.7 million and $16.9 million with related parties for the three months ended June 30, 2026 and 2025, respectively, and $12.0 million and $30.7 million with related parties for the six months ended June 30, 2026 and 2025, respectively)**: 707,331,000 US dollars
- **Cost of revenue (calculated)**: 505,694,000 US dollars
- **Gross profit (calculated)**: 201,637,000 US dollars
- **Operating expenses (calculated)**: 54,813,000 US dollars
- **Income from operations**: 146,824,000 US dollars
- **Total other income (expense), net**: 4,839,000 US dollars
- **Income before income taxes**: 151,663,000 US dollars
- **Income tax provision**: 30,301,000 US dollars
- **Net income**: 121,362,000 US dollars
- **Metabolic**: 209,372,000 US dollars
- **Oncology**: 98,279,000 US dollars
- **Other**: 219,067,000 US dollars
- **Central Nervous System**: 59,982,000 US dollars
- **Cardiology**: 82,858,000 US dollars
- **Antiviral And Anti Infective**: 37,773,000 US dollars
- **Total direct costs**: 505,694,000 US dollars
- **Selling, general and administrative**: 48,103,000 US dollars
- **Depreciation**: 6,555,000 US dollars
- **Amortization**: 155,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.